朝聚眼科（02219）于2026年10月8日公告，显示当日公司在香港联交所回购普通股300,000股，占已发行股本约0.0428%。本次回购的最高及最低每股回购价分别为2.50港元和2.375港元，合计动用资金718,080港元，折合约71.81万港元。
公告同时披露，公司现有已发行股本仍为701,460,000股，库藏股数为0股，所回购的股份尚未注销。回购授权于2026年5月12日获得股东大会批准，公司仍可根据授权回购合计70,518,050股。截至本次回购后，公司已根据该授权累计在香港联交所或其他证券交易所回购6,789,500股，占授权决议通过当日已发行股本的约0.963%。公司确认已遵守香港联交所证券上市规则及相关法律法规。
本公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.